Cargando…
The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications
Nintedanib is a synthetic orally active tyrosine kinase inhibitor, whose main action is to inhibit the receptors of the platelet-derived growth factor, fibroblast growth factor and vascular endothelial growth factor families. The drug also affects other kinases, including Src, Flt-3, LCK, LYN. Ninte...
Autores principales: | Grześk, Grzegorz, Woźniak-Wiśniewska, Anita, Błażejewski, Jan, Górny, Bartosz, Wołowiec, Łukasz, Rogowicz, Daniel, Nowaczyk, Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795697/ https://www.ncbi.nlm.nih.gov/pubmed/33396592 http://dx.doi.org/10.3390/ijms22010282 |
Ejemplares similares
-
The Clinical Significance of Drug–Food Interactions of Direct Oral Anticoagulants
por: Grześk, Grzegorz, et al.
Publicado: (2021) -
Therapeutic Drug Monitoring of Direct Oral Anticoagulants in Patients with Extremely Low and High Body Weight—Pilot Study
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
Soluble Guanylyl Cyclase Activators—Promising Therapeutic Option in the Pharmacotherapy of Heart Failure and Pulmonary Hypertension
por: Grześk, Grzegorz, et al.
Publicado: (2023) -
Inclisiran—Safety and Effectiveness of Small Interfering RNA in Inhibition of PCSK-9
por: Wołowiec, Łukasz, et al.
Publicado: (2023) -
Alcohol and Cardiovascular Diseases—Do the Consumption Pattern and Dose Make the Difference?
por: Chudzińska, Małgorzata, et al.
Publicado: (2022)